Assessment of lung cancer patient’s satisfaction with universal health insurance at Port Said Governorate
Keywords:
lung cancer, patient satisfaction, universal health insuranceAbstract
Background: Lung cancer is a type of cancer that begins in the lung. Assessing the level of satisfaction provides actionable insights to improve the healthcare system. Egypt is embarking on a new Universal Health Insurance system (UHIS) to cover all Egyptians by 2032. Aim of the study: The present study aimed to assess lung cancer patient’s satisfaction with universal health Insurance at Port Said Governorate. Design: A descriptive research design was utilized to conduct this study. Sample: A purposive sample used in this study. Sample size: 136 lung cancer patients. Setting: Study conducted at oncology outpatient clinic El Tadamon Specialized Hospital at Port Said Governorate. Tool: An interviewing questionnaire tool divided to two parts, Part1: Consists of A- Socio-demographic characteristics of lung cancer patients, B- Universal health insurance utilization of lung cancer patients, Part II: Patients’ satisfaction adopted tool which contain 7 domains obtained from (Phaswana et al.,2011). Results: The study results revealed that 48.5% of studied lung cancer patients were had moderate level of satisfaction related to their total patient satisfaction. While, 33.8% of them were had high level of satisfaction & 17.7% of studied sample were had low level of satisfaction related their total patient satisfaction.
Downloads
References
Ajua, A & Zhou, Y (2018): Experiences of lung cancer patients regarding their nursing care A literature Review. Bachelor’s thesis. School of Health and Social Service Degree Programme in Nursing. [Online]. Retrieved (2021, April 15) from https://www.theseus.fi/bitstream/handle/10024/151485/Ajua_Ausler___Zhou_Yan.pdf?isAllowed=y&sequence=1
Akin S, Can G, Aydiner A, (2019): Quality of life, symptom experience and distress of lung cancer patients undergoing chemotherapy. Eur J Oncol Nurs. 2019 ;14:400–9. doi:10.1016/j.ejon.2010.01.003. - DOI - PubMed
Almomani R, Al-Ghdabi R, Banyhamdan K (2020): Patients’ satisfaction of health service quality in public hospitals: a PubHosQual analysis. Manag Sci Lett 10(8):1803–181ntion/risk.
Amos CI, Pinney SM, Li Y, (2021):A susceptibility locus on chromosome 6q greatly increases lung cancer risk among light and never smokers. Cancer Res. 2021; 70:2389–2397.
Braile, M., Marcella, S., Marone, G., Galdiero, M. R., Varricchi, G., & Loffredo, S. (2021): The interplay between the immune and the endocannabinoid systems in cancer. Cells, 10(6), 1282.
BrayL, MayCM (2021):"Chapter 74: Neoplasms of the lung". In Jameson JL, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J (eds.). Harrison's Principles of Internal Medi11(4):1387–1395
Dhanasekaran-Kulawik, J., & Trojnar, A. (2020). Lung cancer in women in 21th century. Journal of Thoracic Disease, 12(8), 4398.
Di Lalla V, Patrick H, Siriani-Ayoub N, Kildea J, Hijal T, Alfieri J. Curr Oncol. (2021): Satisfaction among Cancer Patients Undergoing Radiotherapy during the COVID-19 Pandemic: An Institutional Experience. 2021 Apr 10;28(2):1507-1517. doi: 10.3390/curroncol28020142. PMID: 33920247 Free PMC article.
Eldridge L. (2020): Lung Cancer Complications. [Online]. Retrieved (2021, April 10) from https://www.verywellhealth.com/lung-cancer-complications-and-emerg Charshafian S, & Liang SY. (2018). Rapid fire: Infectious disease emergencies in patients with Cancer. Emerg Med Clin North Am; 36(3):493-516. doi:10.1016/j.emc.2018.04.001.encies-2248840.
Han KT, Chang J, Choi DW, Kim S, Kim DJ, Chang YJ, Kim SJ. (2022): Association of institutional transition of cancer care with mortality in elderly patients with lung cancer: a retrospective cohort study using national claim data. BMC Cancer. 2022 Apr 25;22(1):452. doi: 10.1186/s12885-022-09590-5. PMID: 35468762 Free PMC article.
Howlader N, Forjaz G, Mooradian MJ, (2020):The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020;383(7):640-649.
Hulbert A, Jusue-Torres I, Stark A, (2021): Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum. Clin Cancer Res.2021;23(8):1998–2005.
Liu D, Peng H, Sun Q, (2019) :The Indirect Efficacy Comparison of DNA Methylation in Sputum for Early Screening and Auxiliary Detection of Lung Cancer: A Meta-Analysis. Int J Environ Res Public Health. 2019;14(7):699.
Lizama C, Slavova-Azmanova NS, Phillips M, Trevenen ML, Li IW, Johnson CE.(2018): Implementing Endobronchial Ultrasound-Guided (EBUS) for Staging and Diagnosis of Lung Cancer: A Cost Analysis. Med Sci Monit. 2018 Jan 29; 24:582-589.
Marino P, Touzani R, Seguin L, Moulin JF, Palomares M, Cappiello MA, Provansal M, Vittot M, Dermeche S, Launay S, Goncalves A, Bouhnik AD, Gravis G. (2021): Advance Approval of Outpatient Chemotherapy via Phone Call Optimizes Healthcare Delivery without Compromising Patient Satisfaction with Care. Cancers (Basel). 2021 Mar 16;13(6):1337. doi: 10.3390/cancers13061337. PMID: 33809577 Free PMC article.
Mathauer J, Malvezzi M, Negri E, Vecchia CL & Boffetta P (2019). Risk factors for lung cancer worldwide. ERJ Express. doi: 10.1183/13993003.00359-2019.
Midthun, DE. (2021). Clinical manifestations of lung cancer. [Online].retrieved (2021, April 9) from https://www.uptodate.com/contents/clinical-manifestations-of-lung-cancer
Qian CL, Kaslow-Zieve ER, Azoba CC, Horick N, Wang I, Van Seventer E, Newcomb R, Cashavelly BJ, Jackson VA, Ryan DP, Greer JA, El-Jawahri A, Temel JS, Nipp RD (2022): Associations of patient-reported care satisfaction with symptom burden and healthcare use in hospitalized patients with cancer. Support Care Cancer. 2022 May;30(5):4527-4536. doi: 10.1007/s00520-021-06764-y. Epub 2022 Feb 3. PMID: 35112210
Wirsdörfer F, de Leve S, Jendrossek V (2019): Combining Radiotherapy and Immunotherapy in Lung Cancer: Can We Expect Limitations Due to Altered Normal Tissue Toxicity? Int J Mol Sci. 2019;20(1):24.
Zaghloul MS, Bishr MK (2018 ): Radiation oncology in Egypt: A model for Africa. Int J Radiat Oncol Biol Phys 100:539-544.
Zhang Y, Lin Q, Xu T, Deng W, Yu J, Liao Z, Yue J (2020): Out of the darkness and into the light: new strategies for improving treatments for locally advanced non-small cell lung cancer. Cancer Lett. 2020; 421:59-62.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
